中文
Takara Bio Inc
Japan, Manufacturer, Hits: 966, Updated:6/25/2021
Nojihigashi 7-4-38 Kusatsu, Shiga Japan |
Company Profile
-
Takara Bio Inc., a world leader in biotechnology research and development, offers a host of life science research solutions, from enzymes and GMP-grade reagents to contracted cell and gene therapy manufacturing services and is the developer of the RetroNectin reagent, a world standard in gene therapy protocols. Takara Bio is committed to preventing disease and improving the quality of life for all people through the use of biotechnology.
Company News
- Takara Bio Launches High-throughput, Cost-effective qPCR System to Advance Clinical Research 11/21/2024
- Takara Bio Europe Expands Existing Gothenburg Site to Offer Custom Enzyme Manufacturing 10/29/2024
- Launch of a Mutant RNA T7 Polymerase with Highly Reduced Double-stranded RNA Formation 5/16/2024
- Takara Bio Enters into a License Agreement of RetroNectin® with Fondazione Telethon ETS 10/6/2023
- Takara Bio Europe Launched of New High Quality (HQ) Grade mRNA Production Enzymes "T7 RNA Polymera... 9/16/2023
- Takara Bio Europe Announces Launch of CE-IVD Registered RT-qPCR Diagnostic Kit for SARS-CoV-2 10/9/2021
- Takara Bio Europe AB and Boston IVF Fertility Center Announce Partnership for Cell Therapy Applica... 9/22/2021
- Takara Bio Enters into a License and Supply Agreement of RetroNectin® with BioNTech Cell & Ge... 6/25/2021